Sentiment-Signal
12,2
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | orth by specific reference in that filing. Item 5.02. Departure of Directors or Certain Officers; Election of Director |
| 18.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 14.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 21.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t forth by specific reference in that filing. Item 5.02. Departure of Directors or Certain Officers; Election of Direc |
Stammdaten
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Unternehmen & Branche
| Name | TACTILE SYSTEMS TECHNOLOGY INC |
|---|---|
| Ticker | TCMD |
| CIK | 0001027838 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 511,7 Mio. USD |
| Beta | 0,99 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 329,522,000 | 19,086,000 | 0.82 | 273,942,000 | 218,902,000 |
| 2025-09-30 | 10-Q | 85,755,000 | 8,209,000 | 0.36 | 259,177,000 | 204,949,000 |
| 2025-06-30 | 10-Q | 78,905,000 | 3,217,000 | 0.14 | 273,048,000 | 194,926,000 |
| 2025-03-31 | 10-Q | 61,268,000 | -2,974,000 | -0.13 | 280,242,000 | 205,631,000 |
| 2024-12-31 | 10-K | 292,984,000 | 16,960,000 | 0.70 | 297,924,000 | 216,597,000 |
| 2024-09-30 | 10-Q | 73,093,000 | 5,155,000 | 0.21 | 287,724,000 | 207,901,000 |
| 2024-06-30 | 10-Q | 73,218,000 | 4,298,000 | 0.18 | 278,784,000 | 200,676,000 |
| 2024-03-31 | 10-Q | 61,088,000 | -2,209,000 | -0.09 | 272,040,000 | 193,473,000 |
| 2023-12-31 | 10-K | 274,423,000 | 28,515,000 | 1.23 | 281,438,000 | 193,642,000 |
| 2023-09-30 | 10-Q | 69,586,000 | 22,299,000 | 0.94 | 293,307,000 | 182,830,000 |
| 2023-06-30 | 10-Q | 68,339,000 | -100,000 | 0.00 | 273,728,000 | 158,763,000 |
| 2023-03-31 | 10-Q | 58,846,000 | -1,886,000 | -0.09 | 275,501,000 | 156,162,000 |
| 2022-12-31 | 10-K | 246,785,000 | -17,866,000 | -0.89 | 254,996,000 | 121,400,000 |
| 2022-09-30 | 10-Q | 65,262,000 | -2,279,000 | -0.11 | 248,526,000 | 114,397,000 |
| 2022-06-30 | 10-Q | 59,645,000 | -4,640,000 | -0.23 | 237,303,000 | 114,116,000 |
| 2022-03-31 | 10-Q | 47,978,000 | -0.78 | 233,012,000 | 114,978,000 | |
| 2021-12-31 | 10-K | 208,057,000 | -11,811,000 | -0.60 | 244,270,000 | 128,227,000 |
| 2021-09-30 | 10-Q | 52,497,000 | -3,355,000 | -0.17 | 249,395,000 | 132,106,000 |
| 2021-06-30 | 10-Q | 51,060,000 | 1,305,000 | 0.07 | 181,632,000 | 132,716,000 |
| 2021-03-31 | 10-Q | 42,772,000 | -2,266,000 | -0.12 | 175,276,000 | 125,122,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-24 | Burns Kristie | Officer, Sr. VP Mktg & Clinical Affairs | Open Market Sale | -6,246 | 28.94 | -180,764.24 | -123,1% | |
| 2026-02-24 | Birkemeyer Elaine M. | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -7,701 | 28.94 | -222,880.03 | -151,8% | |
| 2026-02-24 | Dodd Sheri Louise | Director, Officer, Chief Executive Officer | Open Market Sale | -10,993 | 28.94 | -318,144.02 | -216,7% | |
| 2026-02-23 | Dodd Sheri Louise | Director, Officer, Chief Executive Officer | Open Market Sale | -537 | 28.69 | -15,406.05 | -10,5% | |
| 2026-02-23 | Burns Kristie | Officer, Sr. VP Mktg & Clinical Affairs | Open Market Sale | -160 | 28.69 | -4,590.29 | -3,1% | |
| 2026-02-23 | Burns Kristie | Officer, Sr. VP Mktg & Clinical Affairs | Open Market Sale | -4,279 | 28.28 | -121,021.67 | -82,4% | |
| 2026-02-23 | Dodd Sheri Louise | Director, Officer, Chief Executive Officer | Open Market Sale | -14,703 | 28.28 | -415,839.07 | -283,2% | |
| 2026-02-23 | Birkemeyer Elaine M. | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -196 | 28.69 | -5,623.08 | -3,8% | |
| 2026-02-23 | Birkemeyer Elaine M. | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -5,322 | 28.28 | -150,520.53 | -102,5% | |
| 2026-01-02 | Burns Kristie | Officer, Sr. VP Mktg & Clinical Affairs | Open Market Sale | -5,139 | 28.85 | -148,260.15 | -101,0% | |
| 2025-05-08 | BURKE WILLIAM W | Director | Open Market Sale | -3,300 | 9.67 | -31,911.00 | -21,7% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.